The Chief Editors of the European Respiratory Journal (ERJ) have selected their highlights from the September issue. Their selection includes: original articles on the effects of sotatercept on haemodynamics and right heart function, and high- versus low-dose prednisolone for sarcoidosis treatment. The issue also features a research letter on the impact of inhaler therapy choice on carbon footprint, as well as editorials on GOLD 2023 by Dave Singh, defining good lung health by Joan B. Soriano and Christine Jenkins, and COPD by Alvar Agusti and Rosa Faner.
Access the Chief Editors' full list | Visit erj.ersjournals.com to browse the the most highly regarded respiratory journal in Europe
No comments:
Post a Comment